Видео ютуба по тегу Steven Feldman

How to Help Patients ACTUALLY Follow Through with Dr. Steve Feldman | Derms on Drugs Ep8
How to Help Patients ACTUALLY Follow Through with Dr. Steve Feldman | Derms on Drugs Ep8
Steven R. Feldman, M.D. - Dermatologist and Skin Pathologist at Wake Forest Baptist Health
Steven R. Feldman, M.D. - Dermatologist and Skin Pathologist at Wake Forest Baptist Health
Dr Steven R. Feldman on the Effect of Metabolic Syndrome on Treatments for Psoriasis
Dr Steven R. Feldman on the Effect of Metabolic Syndrome on Treatments for Psoriasis
Dr Steven Feldman on Managing Psoriasis in Patients With Metabolic Syndrome
Dr Steven Feldman on Managing Psoriasis in Patients With Metabolic Syndrome
Dr. Steve Feldman at Forsyth Medical Center
Dr. Steve Feldman at Forsyth Medical Center
S2 Episode 1: Psoriasis Advocacy: A Model for Every Chronic Disease?
S2 Episode 1: Psoriasis Advocacy: A Model for Every Chronic Disease?
S1 Episode 1: Sage Advice on Psoriasis and Quality-of-Life Assessment
S1 Episode 1: Sage Advice on Psoriasis and Quality-of-Life Assessment
Что вам нужно знать о безрецептурных средствах лечения псориаза
Что вам нужно знать о безрецептурных средствах лечения псориаза
STEVE FELDMAN - LET ME BE FOREVER.wmv TRADUÇÃO
STEVE FELDMAN - LET ME BE FOREVER.wmv TRADUÇÃO
S1 Episode 3: Topical Prescribing Tips for Better Psoriasis Outcomes
S1 Episode 3: Topical Prescribing Tips for Better Psoriasis Outcomes
S1 Episode 5: Psoriasis Oral Agents: What to Know to Prescribe Like a Pro
S1 Episode 5: Psoriasis Oral Agents: What to Know to Prescribe Like a Pro
Navigating Biosimilars: Biologics Landscape (Orange Line)
Navigating Biosimilars: Biologics Landscape (Orange Line)
Biosimilars—Advances in Research and Development
Biosimilars—Advances in Research and Development
S1 Episode 6: Biologics in Psoriasis: A Spectacular Run
S1 Episode 6: Biologics in Psoriasis: A Spectacular Run
S3 Episode 3: Psoriasis and the Mind: A Two-Way Inflammatory Street
S3 Episode 3: Psoriasis and the Mind: A Two-Way Inflammatory Street
Navigating Biosimilars: Implications for Clinicians (Red Line)
Navigating Biosimilars: Implications for Clinicians (Red Line)